FilingReader Intelligence
Nordhealth reports 13.5% quarterly recurring revenue growth
August 19, 2025 at 02:01 PM UTC•By FilingReader AI
Nordhealth reported 13.5% year-on-year quarterly recurring revenue growth to €11.3m in Q2 2025, with total Annual Recurring Revenue reaching €42.3m.
Investments in AI features and DACH market localization reduced Adjusted EBITDA-CAPEX by €1.0m. The company maintained its 12-17% organic growth guidance for 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
OSL:NORDH•Oslo Stock Exchange
News Alerts
Get instant email alerts when Nordhealth AS publishes news
Free account required • Unsubscribe anytime